Clinical research reshapes nicotine regulation - BRG article in ITJ

Coming soon in International Tobacco Journal
We would like to announce an upcoming publication by Dr. Katarzyna Jarus-Dziedzic, MD, PhD, CEO and Principal Investigator at Bio Research Group (BRG).
The article examines how clinical research is reshaping nicotine regulation, with a focus on the increasing importance of real-world data, biomarkers, and clinical evidence in regulatory frameworks across the EU, UK, and United States.
More details coming soon.

 

Go back

News

Increasing Access to Breakthrough Clinical Trials for Patients in Poland

Poland is strengthening its position as one of the leading clinical research hubs in Europe

Read more …

Happy Easter from BioResearch Group

On the occasion of Easter, we would like to extend our warmest wishes of peace, joy, and renewed energy

Read more …

Clinical research reshapes nicotine regulation – new publication by BRG CEO

BioResearch Group (BRG) announces the publication of a new article by Dr Katarzyna Jarus-Dziedzic.

Read more …

BRG’s Contribution to the Advancement of an Innovative Therapy

Phase I clinical trials conducted at BRG play a key role in the development of new therapies

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲